Literature DB >> 6860175

Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis.

P F Bray, L C Bloomer, V C Salmon, M H Bagley, P D Larsen.   

Abstract

We studied infectious and immune mechanisms in demyelinating disease. The clinical diagnosis in this study of 313 consecutive cases of multiple sclerosis (MS) was based on the clinical conclusions of two or more neurologists and definite abnormalities in CSF IgG. Measurement of antibodies to six microbial agents was compared in 313 patients with MS and 406 controls in the same age range. Using a standardized immunofluorescent antibody (IFA) technique, we found a significantly higher prevalence of Epstein-Barr virus (EBV) infection and a higher level of serum viral capsid antigen IgG antibody titer in the MS population than in the controls. The MS population had a lower cytomegalovirus (CMV) infection rate and lower CMV complement fixing antibody production than controls. Except for the higher measles infection rate and antibody titer in patients with MS, data on the other viruses did not differ from controls.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860175     DOI: 10.1001/archneur.1983.04050070036006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  35 in total

1.  Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

Authors:  J Lycke; B Svennerholm; E Hjelmquist; L Frisén; G Badr; M Andersson; A Vahlne; O Andersen
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 2.  Epstein-barr virus: environmental trigger of multiple sclerosis?

Authors:  Jan D Lünemann; Thomas Kamradt; Roland Martin; Christian Münz
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

3.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

4.  Multicenter case-control study of multiple sclerosis and risk factors. Design of study. The Coordinating Center and the Neurological Centers of the Cooperative Group.

Authors: 
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 5.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

6.  Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production.

Authors:  O Santiago; J Gutierrez; A Sorlozano; J de Dios Luna; E Villegas; O Fernandez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-29       Impact factor: 3.267

7.  Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Authors:  R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

8.  Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.

Authors:  Simon N Willis; Christine Stadelmann; Scott J Rodig; Tyler Caron; Stefan Gattenloehner; Scott S Mallozzi; Jill E Roughan; Stefany E Almendinger; Megan M Blewett; Wolfgang Brück; David A Hafler; Kevin C O'Connor
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

9.  EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.

Authors:  Ahmad Nejati; Zabihollah Shoja; Shohreh Shahmahmoodi; Abbas Tafakhori; Yaghoub Mollaei-Kandelous; Farhad Rezaei; Kabir Magaji Hamid; Abbas Mirshafiey; Rozita Doosti; Mohammad Ali Sahraian; Mahmood Mahmoudi; Fazel Shokri; Vince Emery; Sayed Mahdi Marashi
Journal:  Med Microbiol Immunol       Date:  2015-09-13       Impact factor: 3.402

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.